RAF1 and central nervous system cancer: The BRAF V600E mutation inducing the constitutive activity of Raf is frequently detected in low-grade pleomorphic xanthoastrocytoma, ganglioglioma, extra-cerebellar pilocytic astrocytoma, and epithelioid GBMs instead of other types of high-grade glioma (175).